Kim Kardashian is back in the pregnancy game and she’s already booking revenue from a sketchy morning sickness drug. No, Kim isn’t pregnant, at least not officially. But tabloids are reporting she may be planning a third child through a surrogate.
Apparently, that was enough of a hook for her to reach out to her millions of Instagram and Twitter followers today (July 28) with some advice on morning sickness.
She “assured” fans her doctor told her the drug Diclegis is “safe & effective for mom & baby. It’s also easy to recognize – it has the cutest pregnant lady on it!”
Kardashian promoted the drug in 2015 when she was really was pregnant with her second child.
But she was bitch slapped by the federal Food and Drug Administration (FDA) for failing to provide information on drug safety and side effects.
The FDA fired off the warning letter to the drug’s maker Duchesnay USA of Bryn Mawr, Pa.
In a tweet to her 34 million followers, Kim offered up her own first-hand experience.
“OMG. Have you heard about this? As you guys know my #morningsickness has been pretty bad. I tried changing things about my lifestyle, like my diet, but nothing helped, so I talked to my doctor,” she wrote in a Tweets.
He prescribed me #Diclegis, and I felt a lot better and most importantly, it’s been studied and there was no increased risk to the baby. I’m so excited and happy with my results,” she added.
Then she revealed that she was “partnering” with Duchesnay “to raise awareness about treating morning sickness.”
She added another plug in a separate post to “be safe and sure to ask your doctor about the pill with the pregnant woman on it.”
She provided a link to the drug’s Web site that contained safety information. But the FDA said in its letter that the Web site address was insufficient, according to Bloomberg, which broke the story.
“By omitting the risks associated with DICLEGIS, the social media post misleadingly fails to provide material information about the consequences that may result from the use of the drug and suggests that it is safer than has been demonstrated,” the FDA letter said.
This time around, Kim is sticking to the fine print. She lists the potential side effects.
“The most common side effect of Diclegis is drowsiness,” she writes before encouraging pregnant women to visit the drug’s Web site for more information.
Whether that’s enough to satisfy drug enforcers remains to be seen.